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The objective of this study was to assess the occurrence of drug residues in the raw milk
collected from individual farms and milk collection points during 2009e2010 in six
different major regions of Kosovo (Prishtin€e, Gjilan, Mitrovic€e, Pej€e, Gjakov€e, Prizren). In the
present study, a total of 1734 raw milk samples were collected, and qualitatively screened
with two different tests, the Delvotest SP assay and an enzyme-linked receptor-binding
assay (SNAP). Overall, 106 (6.11%) out of 1734 samples examined with Delvotest SP con-
tained possible drug residues (5.12% and 7.51% of samples from 2009 and 2010, respec-
tively). All suspect samples were further analyzed by three distinct enzyme-linked
receptor-binding assays specific for b-lactams (new b-lactam test), tetracyclines (SNAP
tetracycline test), and sulfonamides (SNAP sulfamethazine test). Only the new SNAP b-
lactam test detected residues in 40 out of 52 samples in 2009 and 54 out of 54 suspect
samples in 2010. A confirmatory method based on liquid chromatography-tandem mass
spectrometry was used to confirm the presence of b-lactam drug residues in samples
detected by the enzyme-linked receptor-binding assay. Amoxicillin, penicillin G, and
cloxacillin were the most frequently detected residues and were in a concentration range
between 2.1 mg/kg and 1973 mg/kg. Seventeen of the positive samples exceeded the
maximum residue levels for one or more b-lactam drug. The highest number of positive
milk samples came from the Pej€e Region (58.8%) and Gjakov€e Region (23.5%), and the
lowest number of positive samples originated from Gjilan (5.88%), with no positive samples
detected in two regions, Mitrovic€e and Prizren.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
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Antibiotic residues in milk are of great concern to dairy
farmers, milk processors, regulatory agencies, and con-
sumers. In lactating cows, antimicrobial agents are used
mostly for the therapy of mastitis but are used to treat other
diseases as well. Today, antimicrobial drugs are used to con-
trol, prevent, and treat infection, and to enhance animal
growth and feed efficiency [1]. Currently, approximately 80%
of all food-producing animals receive medication for part or
most of their lives [2]. The most likely cause of violative drug
residues is the failure to observe proscribed withdrawal times
[3e6]. The presence of antimicrobial residues in milk can
engender drug hypersensitivity reactions in milk consumers,
manifested as dermal reactions, asthma, or anaphylactic
shock [7e12]. Antimicrobial drugs can also interfere with the
manufacture of dairy products, decrease acid and flavor pro-
duction associated with butter manufacture, reduce the
curdling of milk, and cause improper ripening of cheeses
[13,14]. Finally, the use of antibiotics can give rise to an in-
crease in antibiotic resistance of pathogenic bacteria and
contribute to a global health crisis [15,16].
In many countries, governmental authorities have estab-
lished monitoring programs to determine the antibiotic levels
in food and set a maximum residue level (MRL) for these
drugs. In the European Union, veterinary drug residue moni-
toring is enforced according to the requirements set down in
Council directive 96/23/EC [18] and Commission Decision 97/
747/EC [19], and the MRLs were fixed according to Regulation
470/2009/CE [20] and Regulation 37/2010/UE [21]. The Kosovo
program of monitoring residues in live animals and animal
products has been in place since 2005. Various analytical
methods in detecting antibiotic residues in milk have been
reported in the literature [17,22]. Microbiological growth in-
hibition, enzyme-linked immunosorbent assays, and chro-
matographic methods are the most commonly used [23,24].
Kosovo’s dairy sector is one of the key sectors in the
development of agriculture and continues to recover after the
war in 1999, when at least half of livestock production was
depleted. Milk production is widespread throughout Kosovo,
with more than 25 dairy processing companies in operation
[25]. These dairies produce some 381,896 tons of milk annu-
ally, and 58,563.45 tons are imported. The market value of
locally produced milk was V35,934,158 and from imports it
was V32,463,988 [26]. In Kosovo, there is currently no moni-
toring of drug residues in milk. Hence, there are no data
concerning the presence of antibiotic residues in milk pro-
duced and marketed in Kosovo. The present study was
therefore designed to assess the presence of antimicrobial
drug residues in raw milk marketed at different regions of
Kosovo.2. Methods
2.1. Samples
A total of 1734 milk samples from individual farms and milk
collection points were collected over a 2-year periodPlease cite this article in press as: Rama A, et al., Assessment of antib
of Food and Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.201(AprileOctober 2009 and FebruaryeNovember 2010) from six
major regions of Kosovo (Prishtin€e, Gjilan, Mitrovic€e, Pej€e,
Gjakov€e, Prizren). In 2009, a total of 1015 milk samples were
collected, 826 samples from milk collection points and 189
samples from individual farms. In 2010, in total of 719 milk
samples were collected, 635 samples from milk collection
points and 84 samples from individual farms. Allmilk samples
were stored at 4C until analysis. For additional investigations,
drug-positive milk samples were stored at e20C for 3 weeks.
2.2. Screening methods
Antimicrobial drug screening tests were performed at the
Kosovo Food and Veterinary Agency in Prishtina, Kosovo. The
screening tests used were the Delvotest SP assay supplied by
DSM (DSM Food Specialities, Dairy Ingredients, Delft, The
Netherlands), and enzyme-linked receptor-binding assays
(SNAP tests) provided by IDEXX Lab. Inc. (Westbrook, ME,
USA). All drug-positive samples detected by the Delvotest SP
were checked with enzyme-linked receptor-binding assays
specific for b-lactams, tetracycline, and sulfonamides. Positive
samples confirmed by SNAP test were further quantitatively
analyzed using liquid chromatography-tandem mass spec-
trometry (LC-MS/MS).
2.2.1. Reagents and standard solutions for screening tests
Penicillin G (PNG) potassium salt and sulfamethazine were
obtained from Fluka (St. Louis, MO, USA), Tetracycline hydro-
chloridewas obtained from Sigma (St. Louis, MO, USA). For the
preparation of negative control, drug-freemilk from cows that
had not been treatedwith an antibiotic for at least 30 dayswas
collected. The milk was collected from the experimental farm
of the Agriculture and Veterinary Faculty (Prishtina, Kosovo).
A stock solution of PNG potassium was prepared in a 100-
mL volumetric flask, adding 11.17 mg penicillin and distilled
water to the target volume. From this solution, 1 mL (100 mg
penicillin/mL) was diluted 100-fold with distilled water (i.e., to
a final concentration of 1 mg penicillin/mL).
For preparation of drug-spiked milk samples, drug con-
centrations of  40 mg/L of milk were prepared by adding the
appropriate amount of stock solution directly tomilk samples.
The equivalent volume of milk was removed prior to adding
the appropriate volume of stock solution. The amount added
was always ˂ 0.5% of the total volume. Penicillin-G potassium
was present at a final concentration of 4 mg/L for the positive
control sample, whereas tetracycline and sulfamethazine
were added to milk to achieve final concentrations of 60 mg/L
and 100 mg/L, respectively.
2.2.2. Delvotest SP microbial test
The qualitative analysis of PNG residues in milk was per-
formed using the Delvotest SP assay as described by Suhren
and Beukers [27]. This method is based on the susceptibilities
of bacteria to different antibiotics. The method was carried
out according to the instructions by the manufacturer.
2.2.3. Enzyme-linked receptor-binding assays (SNAP tests)
Positive samples found by Delvotest SP were subjected to
further testing with enzyme-linked receptor-binding assays
(SNAP tests). The New SNAP Beta-lactam Test Kit, SNAPacterial drug residues in milk for consumption in Kosovo, Journal
6.07.007
Table 1 e Chromatographic conditions (timing and
percentages of linear gradients used) and MS/MS
acquisition conditions for b-lactams.
Time
(min)
Percentage acetic
acid 0.005%
Percentage ACN
with 0.005% acetic acid
0.0 100 0
8.00 10 90
9.00 10 90
10.00 100 0
14.00 100 0
Flow rate (mL/min) 0.2
Injection volume (mL) 10
Autosampler temperature (C) 4
Column temperature (C) 30
Acquisition conditions
Analyte Precursor
ion (m/z)
Collision
energy (%)
Product
ion (m/z)
AMOXY (ESI þ) 366 15 305, 234, 211,
208,a 160, 114349 18
AMPI (ESI þ) 350 15 333, 305, 191,
174, 160,a 106
PEN G (ESI e) 333 20 289, 192a
CLOXA (ESI e) 434 15 390,a 293
DICLOXA (ESI e) 468 15 424,a 327
Ionization conditions for positive and negative mode
Sheath gas flow (arbitrary unit) 30
Auxiliary gas flow (arbitrary unit) 15
Capillary temperature (C) 275
ACN¼ acetonitrile; AMOXY¼ amoxicillin; AMPI¼ ampicillin; CLOX-
A¼ cloxacillin; DICLOXA¼ dicloxacillin; ESI¼ electrospray ioniza-
tion; MS/MS¼ tandem mass spectrometry; PEN G¼ penicillin G.
a Product ion used for quantification.
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screen antibiotic residues in milk. The SNAP tests were per-
formed in accordance with the manufacturer's instructions.
2.3. Confirmatory methods
2.3.1. Reagents and analytical standards
High performance liquid chromatography (HPLC)-grade
methanol, acetonitrile, n-hexane, and acetic acid were ob-
tained from Sigma-Aldrich (St. Louis, MO, USA). Water was
HPLC grade andwas preparedwith aMilli-Q system (Millipore,
Bedford, MA, USA). Sodium phosphate buffer (0.05M, pH 7.5)
was prepared by dissolving 0.73 g of NaH2PO4 dihydrate and
3.61 g of Na2HPO4 monohydrate (Sigma-Aldrich) in 500 mL
water. Ammonium acetate (0.05M)was prepared by dissolving
1.92 g of ammonium acetate in 500 mL water and adjusted to
pH 7.5 by addition of ammonium hydroxide.
Analytical standard-grade (VETRANAL) amoxicillin trihy-
drate (purity 99.3%), ampicillin trihydrate (purity 99.7%,), PNG
sodium salt (purity 99.4%,), cloxacillin sodium salt mono-
hydrate (purity 98.9%), and dicloxacillin sodium salt mono-
hydrate (purity 99.4%) were purchased from Sigma-Aldrich.
Individual stock solutions of amoxicillin (AMX), ampicillin
(AMP), PNG, cloxacillin (CXA) and dicloxacillin (DCX) were
prepared to achieve a final concentration of 1000 mg/mL by
dissolving each exactly weighed drug (10 mg) in 10 mL of
water/acetonitrile (80:20, v/v; AMX and AMP) or water/aceto-
nitrile (50:50, v/v; PNG, CXA, DCX). All solutions were stored at
e20C in amber glass containers.
Intermediate standard mixture solutions containing 10 mg/
mL for AMX, AMP, PNG, and 75 mg/mL for CXA and DCX were
prepared by mixing the appropriate amount of each stock
standard solution in water/acetonitrile (50:50, v/v) with stor-
age at 4C.
Working standard mixture solutions containing 0.1 mg/mL
for AMX, AMP, PNG or 0.75 mg/mL for CXA and DCX were
prepared daily by diluting the intermediate standard solution
with water/acetonitrile (50:50, v/v). These solutions were used
for spiking negative milk samples and for constructing cali-
bration curves.
2.3.2. Sample preparation and LC-MS/MS conditions
All milk samples determined to be positive for drug residues
were stored at e80C until analysis. The sample preparation
was a modification of the procedure described by Holstage
et al [28]. Briefly, residues from 5-g milk samples were
extractedwith 10mL of acetonitrile bymechanical shaking for
10 minutes. The organic phase was separated from solid res-
idue by centrifugation at 4000g for 5 minutes at 4C. The su-
pernatant was transferred in a second 15-mL centrifuge tube,
and the extraction was repeated a second time by adding
10 mL of acetonitrile in the centrifuge tube with the precipi-
tate. After shaking and centrifugation at 4000g for 5 minutes,
the acetonitrile fractions were combined and evaporated to
0.5 mL volume under an air stream at 50C using a TurboVap
evaporator (Zymarck, Hopkinton, MA, USA). A volume of 4 mL
phosphate buffer (0.05M at pH 7.5) was added to each sample,
and the extract was defatted with 5 mL n-hexane. After
centrifugation at 4000g for 5 minutes, the upper organic layer
was eliminated and the aqueous phase was purified throughPlease cite this article in press as: Rama A, et al., Assessment of antib
of Food and Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016STRATA-X SPE cartridges (60 mg, 3 mL) obtained from Phe-
nomenex (Torrance, CA, USA). Each cartridge was previously
activated with 2 mL methanol, 2 mL distilled water, and 2 mL
phosphate buffer (0.05M at pH 7.5).
The loaded cartridges were washed with 3 mL phosphate
buffer (0.05M at pH 7.5) and 1 mL distilled water, then eluted
with 5 mL acetonitrile. The eluate was dried under an air
stream at 50C, and the residue was redissolved with 500 mL
ammonium acetate (0.05M at pH 7.5) in acetonitrile (90:10, v/
v). The samples were sonicated for 10 minutes, centrifuged at
14,000g for 15 minutes and subsequently transferred into LC
vials for LC-MS/MS analysis.
All analyses were performed on a liquid chromatographic
system (LC) Accela 600 (Thermo Fischer Scientific, San Jose,
CA, USA) provided with a quaternary solvent delivery system,
a column heater module, and a sampling cooling device,
coupled to an LTQ ion trap from Thermo Fischer Scientific.
The chromatographic separation was achieved with a Kinetex
C18 column (inner diameter, 2.1 mm; length, 100 mm; particle
size, 2.6 mm; Phenomenex Ltd.). The mass analyzer was set in
the full scan monitoring mode. The analytical conditions are
summarized in Table 1.
2.3.3. Method validation
The confirmatory method for b-lactams was validated to be in
compliance with the Commission Decision 657/2002/EC [29].acterial drug residues in milk for consumption in Kosovo, Journal
.07.007
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to matrix effects, all analytes were quantified by calibration
curves prepared daily by processing blank milk samples and
spiking the final evaporated extract with a mixture of drugs at
four concentration levels including zero (blank). An external
standard calibration was used for the quantification of all
analytes.
The linearity of the methods was tested in milk over the
range of 0.5e10 mg/kg for AMX, AMP, and PNG, and over the
range of 2.5e90 mg/kg for CXA and DCX. All the calibration
curves tested were characterized by excellent linear-
itydverified by lack-of-fit testsdand by satisfactory correla-
tion coefficients (r2) greater than 0.98. Specificity was verified
by the lack of chromatographic interference at the retention
time of the analytes of interest on a minimum number of 20
blank milk samples.
Because no certified reference materials were available for
b-lactams, to determine trueness and precision, recovery and
repeatability were evaluated by means of spiked blank sam-
ples around theMRL of each analyte. Blankmilk sampleswere
spiked prior to the beginning of the extraction procedure with
the analytes under investigation: three concentrations levels
were chosen (0.5MRL, 1MRL, 1.5MRL), and six replicates
were carried out for each spiking level and repeated on 3Table 2 e Validation results for the confirmation of b-lactam re
repeatability (r %), and intralaboratory reproducibility (R %) in
LC-MS/MS
Intra- & interday repeatability for the determination of b-lactam
Compound Spike
level
(mg/kg)
Day 1 (n¼ 6) Day 2 (n¼
Mean
found
(mg/kg)
RSD
(%)
Recovery
(%)
Mean
found
(mg/kg)
RSD
(%)
R
AMOXY 2.0 1.8 13.6 88.3 2.0 6.6
4.0 3.9 12.5 97.3 3.9 6.6
6.0 5.8 7.9 96.1 5.9 7.6
CCa 4.9 mg/kg
CCb 5.7 mg/kg
AMPI 2.0 1.8 13.8 90.5 1.9 5.8
4.0 3.8 11.9 95.6 4.3 8.6
6.0 5.8 8.5 96.8 6.1 11.9
CCa 4.7 mg/kg
CCb 5.5 mg/kg
PEN G 2.0 1.9 10.2 93.0 2.2 11.1
4.0 3.8 14.8 95.5 4.1 11.4
6.0 5.4 13.3 89.6 6.1 9.7
CCa 5.5 mg/kg
CCb 7.0 mg/kg
CLOXA 15 11.5 9.1 76.5 15.5 5.5
30 24.2 14.4 80.6 28.8 3.5
45 41.5 8.7 92.2 45.7 6.3
CCa 35.8 mg/kg
CCb 41.6 mg/kg
DICLOXA 15 16.5 11.8 109.7 14.8 11.6
30 31.8 12.2 105.9 30.3 8.5
45 45.1 7.3 100.3 43.0 8.6
CCa 35.3 mg/kg
CCb 40.6 mg/kg
AMOXY¼ amoxicillin; AMPI¼ ampicillin; CLOXA¼ cloxacillin; DICLOXA
spectrometry; PEN G¼ penicillin G; RSD¼ relative standard deviation.
Please cite this article in press as: Rama A, et al., Assessment of antib
of Food and Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.201different days for a total of 72 samples. The precision of the
method was evaluated by calculating the relative standard
deviation (RSD %) in intraday repeatability conditions (r %,
RSD calculated from the six replicates for each spiking level)
and in intralaboratory reproducibility conditions (R %, RSD
calculated from the 18 replicates for each spiking level over 3
days). Trueness was calculated by dividing the mean
measured value by the fortification level and multiplying by
100 to express the result as a percentage.
The results, which are shown in Table 2, reveal that all RSD
% values, for intraday repeatability (r %) and intralaboratory
reproducibility (R%) ranging from 3.5% to 14.8% and from 6.8%
to 13.8%, respectively, meet the requirement of the Commis-
sion Decision 2002/657/EC at all fortification levels. The true-
ness, expressed as the relative recovery, ranged from 88.3% to
108.6% for AMX, AMP, and PNG, and from 76.5% to 109.7% for
CXA and DCX, which are in agreement with the limits (from
1.0 mg/kg to 10 mg/kg, 70e110%, and 10 mg/kg, and 80e110%)
established by Commission Decision 2002/657/EC.
CCa and CCß were determined by analyzing 20 blank
samples fortified at their corresponding permitted limit. CCa
was calculated as the mean measured concentration at the
MRL of each compound plus 1.64 times the standard deviation
(SD) of intraday precision at this concentration; CCß wassidues in milk: results of trueness (recovery in %), intraday
spiked milk samples.
s, in fortified milk samples
6) Day 3 (n¼ 6) Interday (n¼ 18)
ecovery
(%)
Mean
found
(mg/kg)
RSD
(%)
Recovery
(%)
Mean
found
(mg/kg)
RSD
(%)
Recovery
(%)
101.5 2.0 11.8 100.1 1.9 11.9 96.6
97.8 4.3 11.5 107.9 4.0 11.1 101.0
98.6 6.0 10.8 100.0 5.9 8.6 98.2
96.1 2.1 7.0 103.5 1.9 10.4 96.7
106.5 3.9 10.9 96.5 4.0 11.1 99.5
101.4 6.1 10.7 101.2 6.0 10.1 99.8
108.6 2.0 15.1 99.4 2.0 13.3 100.3
103.1 4.0 10.1 100.6 4.0 11.9 99.8
100.9 6.0 7.1 99.8 5.8 11.0 96.8
103.1 15.1 9.3 100.7 14.2 13.8 94.9
96.2 29.8 10.9 99.2 27.6 13.2 92.0
101.5 45.1 6.3 100.2 44.1 7.9 97.9
98.9 15.1 5.8 100.4 15.4 10.7 103.0
100.9 29.9 7.1 99.6 30.6 9.5 102.1
96.6 45.1 4.1 100.1 44.4 6.8 98.7
¼ dicloxacillin; LC-MS/MS¼ liquid chromatography-tandem mass
acterial drug residues in milk for consumption in Kosovo, Journal
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ability at CCa [29,30].Figure 1 e Distribution of b-lactam positive milk samples
in different regions of Kosovo (2009 and 2010).3. Results
3.1. Results by screening methods
The qualitative detection of antibiotic residues by the Delv-
otest SP screening test applied to 1734 raw milk samples
collected over 2 years (2009e2010) led to the identification of
106 positive samples (6.11%), and 1628 negative samples
(93.9%). In 2009, 52 out of 1015 samples were drug-positive
(5.12%), and in 2010, 54 out of 719 samples were positive
(7.51%). The total number of drug-positive samples found in
the study is shown in Table 3. Enzyme-linked receptor-bind-
ing assay (SNAP) test was used to check the positive samples,
thus using the new b-lactam test for the determination of
antibiotic residues in positive samplesd40/52 in 2009 and 54/
54 in 2010 samples were found to be positive; no positive
samples were detected by SNAP tetracycline test and SNAP
sulfamethazine test (see Table 4).
In terms of the regional distribution of milk samples con-
taining drug residues, the highest numbers of positive milk
samples were obtained from the Pej€e (58.8%) and Gjakov€e
(23.5%) regions of Kosovo, whereas relatively low numbers of
positive milk samples were from Gjilan (5.88%), and no drug-
positive samples were detected in Mitrovic€e or Prizren
(Figure 1).
3.2. Confirmation of qualitative results
Fifty-five out of 106 drug-positive samples were analyzed by
LC-MS/MS, and b-lactam antimicrobial drug residues were
detected in 32 samples. The concentrations of b-lactams
(AMX, AMP, PNG, CXA) in these samples ranged from 2.1 mg/kg
to 1973 mg/kg, as shown in Table 5. Eighteen samples out of 55
would be considered noncompliant because the concentra-
tions of one or more b-lactam residues exceeded the CCa of 5
for AMX, 7 for PNG, 2 for CXA, 1 for AMP, 1 for both AMP and
CXA, 1 for both AMP and PNG, and 1 for the combination ofTable 3 e Rawmilk samples screened by the Delvotest SP
test to detect the presence of antibiotic residues in 2009
and 2010.
Raw milk No. of samples No. of positive samples, n (%)
2009 1015 52 (5.12)
2010 718 54 (7.51)
Total 1734 106 (6.11)
Table 4 e Raw milk samples screened by SNAP test in 2009 an
Analytical test used 2009
No. of samples No. of negative
samples
No.
s
New SNAP beta lactam test 52 0
SNAP tetracycline test 52 52
SNAP sulfamethazine test 52 52
Please cite this article in press as: Rama A, et al., Assessment of antib
of Food and Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016AMP, CXA, and PNG. Seven samples were deemed compliant
with respect to the established CCa, and six additional milk
samples contained only trace amounts of b-lactam residues
that were not quantified because they were below the limit of
quantification.4. Discussion
This study confirms that penicillins are the main group of
antibiotics detected in milk samples, and these findings are in
agreement with the observations reported by several other
investigative teams [28,31e38]. This is likely to be a reflection
of the frequent use of chemotherapeutic drugs in the therapy
and prevention of specific diseases in dairy cattle and the use
of intra-mammary infusions containing b-lactams for the
treatment of mastitis. A report by Chung et al [23] identified 21
antibiotic contaminated samples out of 269 analyzed milk
samples, representing 7.8% of the total. Khaskheli et al [39]
analyzed 137 milk samples and, using the qualitative micro-
bial method with Bacillus subtilis in plates for detection of b-
lactam residues, identified 87 samples (63.5%) as negative and
50 samples (36.5%) as positive. In Romania, a survey was
conducted [40], in which 124 milk samples (4.45%) out of a
total of 2785 were found to be contaminated with antibiotic
residues, with 2531 samples (90.88%) free of antibiotic resi-
dues. Nikolic et al [41] analyzed 6161 raw milk samples in
Montenegro, of which 7.84% of the samples were drug-
positive, and in Croatia [42], a very low percentage (0.69%
[42]) or no milk samples [43,44] containing antibiotics were
detected above the maximum residue levels (MRLs)d 2010.
2010
of positive
amples
No. of samples No. of negative
samples
No. of positive
samples
40 54 0 54
0 54 54 0
0 54 54 0
acterial drug residues in milk for consumption in Kosovo, Journal
.07.007
Table 5 e Confirmatory results for suspect samples analyzed by LC-MS/MS.
Sample AMPI (mg/kg) AMOXY (mg/kg) PEN G (mg/kg) CLOXA (mg/kg) DICLOXA (mg/kg)
2009
DP021 nd nd C (2.2) nd nd
BF037 nd nd nd nd nd
DP071 nd nd nd nd nd
BB110 nd nd NC (98) nd nd
DE115 nd nd <LoQ nd nd
BB120 nd nd nd nd nd
EI121 nd nd NC (1973) nd nd
DO125 nd nd nd nd nd
GO128 nd nd nd nd nd
DE138 nd nd NC (5.5) nd nd
DP146 nd nd nd nd nd
DE168 nd NC (7.2) nd nd nd
DP175 nd nd C (20) nd nd
DE185 nd C (2.1) C (4.1) nd nd
DE191 nd NC (14) nd nd nd
DP195 nd NC (7.6) nd nd nd
DY196 nd nd nd nd nd
IK196 NC (8.9) nd nd C (20) nd
FV200 nd nd nd nd nd
FV201 NC (171) nd <LoQ NC (439) nd
PM203 nd nd nd nd nd
BD206 nd nd <LoQ nd nd
BL209 <LoQ nd nd nd nd
DO213 nd nd nd nd nd
GO214 nd nd nd nd nd
2010
KA216 <LoQ nd nd <LoQ nd
GO236 nd nd NC (24) nd nd
GO244 nd nd NC (24) nd nd
KA270 nd nd nd nd nd
KP291 nd nd NC (6.4) nd nd
DE292 nd nd nd <LoQ nd
DK293 nd nd nd nd nd
IK294 <LoQ nd C (5.1) <LoQ nd
EI294 <LoQ nd nd NC (42) nd
DY296 nd nd nd nd nd
DP297 nd NC (15) nd nd nd
BD298 nd nd nd nd nd
DO299 nd nd nd NC (49) nd
BL317 nd nd nd nd nd
DE318 nd C (4.6) nd nd nd
DE319 nd nd nd nd nd
FR320 NC (784) nd NC (156) NC (542) nd
KP379 nd nd NC (6.9) nd nd
GA390 nd nd nd <LoQ nd
DO391 nd nd nd nd nd
DP392 nd nd nd nd nd
PM393 nd nd nd <LoQ nd
FV394 nd nd nd nd nd
GO426 nd nd nd nd nd
DP461 C (2.5) nd nd C (32.4) nd
DP514 nd NC (43) nd nd nd
GO554 nd nd nd nd nd
DE587 NC (7.0) nd C (15) nd nd
KP661 nd nd C (5.1) ND nd
DK671 nd nd nd nd nd
AMOXY¼ amoxicillin; AMPI¼ ampicillin; C¼ compliant (sample containing a concentration of b-lactam residues lower or equal to CCa);
CLOXA¼ cloxacillin; DICLOXA¼ dicloxacillin; LC-MS/MS¼ liquid chromatography-tandem mass spectrometry; NC¼not compliant (sample
containing a concentration of b-lactam residues higher than CCa); LoQ¼ limit of quantification (corresponding to the 1st spiking level used in
validation of the LC-MS/MS method: 2 mg/kg for AMP, AMX, PNG; 15 mg/kg for CXA and DCX); nd¼ not detected; PEN G¼ penicillin G;
RSD¼ relative standard deviation.
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Similar results were obtained in raw milk samples from
Slovenia [45]. By contrast, tetracyclines (48.9%), sulfonamides
(18.4%), and quinolones (6.8%) were found in milk samples
from Macedonia, although drug residues were below the
maximum residue limits [46].5. Conclusion
The present investigation is the first performed in Kosovo to
evaluate the presence of antibiotic residues in foodstuffs, and
in particular, milk and dairy products. Our results indicate
that b-lactams are the main class of antimicrobial drugs
detected in milk intended for human consumption in Kosovo.
The considerable levels of residues detected in raw milk,
although regionally limited, are a human health concern that
prompts a number of recommendations addressed to public
authorities, veterinarians, livestock producers, and con-
sumers. In addition to implementing appropriate regulatory
legislation and providing an adequately controlled sampling
network, we should be able to provide effective means for
food control with appropriate risk assessments that will instill
confidence in consumers. Competent authorities should
establish and maintain continuous dairy monitoring pro-
grams to ensure risk-freemilk products to Kosovo consumers.
In addition, there is a pressing need for additional research to
accurately assess other aspects of this problem and identify
effective corrective actions that are designed to reduce milk
contaminants.Conflicts of interest
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